BioNTech Dives As Pfizer Partner Reports Lagging Covid Vaccine Sales, Guidance

BioNTech Dives As Pfizer Partner Reports Lagging Covid Vaccine Sales, Guidance

BioNTech lagged second-quarter expectations and issued light 2022 guidance on Monday, leading BNTX stock to dive.